Shots: The P-II LIMT study involves assessing of (peg INF-Lambda) Lambda 120/180 μg SC IV qw for 48wks. in ratio (1:1) (N=33) in patients with chronic HDV, testing safety, efficacy […]readmore
Tags : Hepatitis Delta Virus (HDV) Infection